Codis, a contract development and manufacturing organisation specialising in spray drying and advanced particle engineering, has completed the acquisition of Catalent’s Nottingham facility, the company announced on Monday.
What the deal brings to Nottingham
The purchase brings development‑scale spray drying, oral solid dose (OSD) formulation work, analytical services, clinical supply and small‑scale commercial manufacturing under Codis’ umbrella in Nottingham. The site’s staff, described as having more than two decades of formulation and clinical‑supply expertise, have joined Codis.
- Development and formulation capabilities now located in Nottingham
- Small‑scale commercial manufacturing added to Codis’ UK operations
- Integration with Codis’ commercial spray‑drying capacity in Haverhill
"We are delighted to welcome the Nottingham team into the Codis family. Their scientific strength, development experience, and long track record of delivering high‑quality spray‑dried and oral solid dose solutions make them an exceptional addition to our organisation."
Codis says the combination of the Nottingham site with its larger commercial spray‑drying facility in Haverhill will create a continuous pathway from early development through to commercial intermediates and final dose forms across the region.
Local and regional implications
For Nottingham, the acquisition retains local specialist capability in pharmaceutical formulation and clinical supply within the city. The Nottingham general manager, who will join Codis’ executive team, said his team were looking forward to contributing to the enlarged service offering.
| Site | Main role |
|---|---|
| Nottingham | Development‑scale spray drying, OSD formulation, analytical services, clinical supply, small‑scale commercial manufacturing |
| Haverhill | Commercial‑scale spray drying |
Neither Codis nor Catalent disclosed financial terms or detailed staffing figures in the announcement. Questions about any planned investment at the Nottingham site beyond integration with Codis’ network, or potential changes to employment levels, remain unanswered in the statement.
The deal underlines ongoing consolidation in specialised pharmaceutical manufacturing, and strengthens the East of England and Nottinghamshire as a cluster for spray‑drying and particle engineering services.
